Report Highlights
-
The potential market for antisense therapeutics in 2007 is estimated to be more than $3.15 billion.
-
This is about 3.1% of the combined total market for all applications of antisense therapeutics.
-
By 2007, the treatment of immunological disorders will be valued at more than $1.7 billion.
-
In five years, the treatment of cancer will be valued at $760 million, infectious disease at $310 million, and all other applications in excess of $330 million.
INTRODUCTION
The use of antisense compounds as therapeutics is beginning to gain momentum. After several years of developing the technologies needed to succeed, antisense therapeutics are gaining a reputation as therapeutics with excellent safety profiles that are well tolerated by patients and easy to administer. This was shown in 1998 when the first antisense therapeutic, Vitravene, was approved for treating CMV retinitis. Vitravene gave creditability to all antisense therapeutics and launched them into the competitive world of therapeutics development.
There now are a wide variety of applications in which the antisense therapeutics being developed include cancer, coronary heart disease, type 2 diabetes, immunological disorders, infectious diseases, polycystic kidney disease, and retinal disorders. Currently, 42 antisense therapeutics are in development. All but one are either in the preclinical or clinical development stages.
This report provides an overview of the gene expression process and how antisense compounds can be used to control gene expression. Included is summary of the technological advances made in antisense compounds and how each impacts antisense therapeutics. The applications of antisense therapeutics and strategies used by each company to meet the needs of the application are examined, with market estimates projected through 2007. This analysis will be invaluable, therefore, to decision makers in the biotechnology and pharmaceutical industries.
SCOPE OF STUDY
This report includes:
- Antisense technologies review
- Discussion of antisense therapeutic applications: cancer, coronary heart disease, type 2 diabetes, immunological disorders, infectious diseases, polycystic kidney disease and retinal disorders
- Analysis of the markets for antisense therapeutic applications
- Profiles of 18 companies and their antisense therapeutic products
- Antisense industry structure.
METHODOLOGY USED IN STUDY
This report forecasts the potential markets for antisense therapeutics. The data used in these forecasts were obtained from members of the antisense therapeutic industry, research institutes, foundations, governmental and international organizations, scientific literature, as well as from annual reports and other publications from antisense companies and other pharmaceutical companies.
ANALYST CREDENTIALS
Patricia Lingenfelter has a Master of Science in Finance from Seattle University and a B.S. in biochemistry from Western Washington University. She has over 13 years of scientific work experience in both academic and commercial research settings. Most recently, she has combined her research and training in a biotechnology development setting.
Related Reports
Track the Latest Global Tariff Developments
In today's fast-paced global economy, tariffs are no longer static—they are dynamic levers shaped by geopolitical realignments, supply chain vulnerabilities, inflationary pressures, and sustainability-driven trade reforms. As governments worldwide recalibrate their trade strategies, businesses are left to navigate a maze of shifting rules, rising costs, and regulatory uncertainty.
Our analysis empowers you with real-time updates and in-depth expert analysis on all facets of global tariff activity. From new trade agreements and sanctions to abrupt tariff hikes and retaliatory duties, we monitor developments across borders, sectors, and industries—so you don't have to.
Whether it's the ongoing U.S.–China trade dynamics, the evolving EU Carbon Border Adjustment Mechanism (CBAM), or the emerging policies in India, ASEAN, and Latin America, we provide full-spectrum coverage. We also track multilateral trade negotiations, World Trade Organization (WTO) rulings, and sector-specific duty structures—ensuring you are always ahead of global trade shifts.
With our analysis, you can stay informed, identify risks, and confidently respond to tariff changes—no matter where you operate.
Ready to see what tariff means for your business?
Consult with our experts or request your custom Tariff Impact Brife today
Stay Informed, Stay Competitive
In today's interconnected and unpredictable global economy, staying ahead of tariff shifts is not just important—it's essential. BCC Research provides decision-makers with trusted, research-driven insights that turn uncertainty into opportunity.
Our in-depth market analysis and trade intelligence help you decode how tariff changes impact your specific sector—manufacturing, healthcare, technology, agriculture, or energy. We break down complex data into actionable knowledge through comprehensive reports, expert commentaries, and sector-focused forecasts.
Our analysis includes:
- Thorough breakdowns of current and proposed tariff policies and how they affect regional and global trade flows.
- Sector-specific implications, helping you understand the strategic impact on sourcing, pricing, and competitiveness.
- Forward-looking insights to support risk management, planning, and response strategies for evolving trade conditions.
With BCC Research, you gain more than just information—you gain clarity and confidence to make well-informed decisions in a volatile trade environment.
Don't let tariffs catch you off guard—let our insights guide your strategy.
Recent Reports
Global DNA Read, Write, and Edit Market
The global market for DNA read, write, and edit was valued at $25.9 billion in 2025 and is estimated to reach $67.7 billion by 2030, at a compound annual growth rate (CAGR) of 21.2% from 2025 through 2030.
Validation, Calibration, and Standardization in the Life Sciences Market
The global market for validation, calibration, and standardization in life sciences was valued at $2.8 billion in 2025 and is estimated to reach $3.9 billion by 2030, at a compound annual growth rate (CAGR) of 6.7% from 2025 through 2030.
Cloud Computing in Cell Biology, Genomics and Drug Development: Global Markets
The global market for cloud computing in cell biology, genomics and drug development is estimated to grow from $7.2 billion in 2025 to $15.6 billion by the end of 2030, at a compound annual growth rate (CAGR) of 16.7% from 2025 through 2030.
Decentralized Clinical Trials: Global Markets
The report provides an overview of the global decentralized clinical trials (DCT) market and analyzes market trends. It includes global revenue ($ Million) for the base year data of 2024 and for the forecast period 2025 through 2030.
Central Nervous System (CNS) Biomarkers: Technologies and Global Markets
The global market for central nervous system (CNS) biomarkers is estimated to grow from $7.6 billion in 2025 to reach $13.8 billion by the end of 2030, at a compound annual growth rate (CAGR) of 12.6% from 2025 through 2030.
Top Trending Reports
Stem Cell and Regenerative Therapy: Global Markets
The global market for stem cell and regenerative therapy is projected to grow from an estimated $16.7 billion in 2025 to $43.8 billion by 2030, at a compound annual growth rate (CAGR) of 21.3% from 2025 to 2030.
Infusion Pumps and Devices: Technologies and Global Markets
The global market for infusion pumps and devices is expected to grow from $9.7 billion in 2025 and is projected to reach $14.2 billion by the end of 2030, at a compound annual growth rate (CAGR) of 7.9% during the forecast period of 2025 to 2030.
Validation, Calibration, and Standardization in the Life Sciences Market
The global market for validation, calibration, and standardization in life sciences was valued at $2.8 billion in 2025 and is estimated to reach $3.9 billion by 2030, at a compound annual growth rate (CAGR) of 6.7% from 2025 through 2030.
Noninvasive Cancer Diagnostics: Technologies and Global Markets
The global market for noninvasive cancer diagnostic technologies is expected to grow from $119.9 billion in 2025 and is projected to reach $165.2 billion by the end of 2030, at a compound annual growth rate (CAGR) of 6.6% during the forecast period of 2025 to 2030.
Neuroprotective Agents: Therapeutic Applications and Global Markets
The global market for neuroprotective agents is expected to grow from $43.9 billion in 2025 and is projected to reach $60.9 billion by the end of 2030, at a compound annual growth rate (CAGR) of 6.7% during the forecast period of 2025 to 2030.
Become A Member
BCC Research offers a comprehensive library of reports, granting members unlimited access to data, insights, and market intelligence for informed business decisions, while actively supporting members in their evolving journeys and prioritizing high-quality, relevant topics based on continuous engagement with the research community.
Find Out MoreCustom Consulting
BCC Research emphasizes the importance of organizations leveraging highly customized market insights aligned with specific strategic business objectives through direct engagement with primary sources and proprietary forecasting models for profitable decision-making in maximizing growth opportunities and minimizing risks.
Customize NowScorecard
The Venture Scorecard provides commercialization offices and decision makers with expert analysis, offering strategic insights crucial for aligning objectives with market realities at various stages of commercializing new products or evaluating investment opportunities, from opportunity assessment to growth planning.
Find Out MoreInnovation Spotlight
Our industry experts offer strategic guidance to maximize the market potential of commercialized products, patents, and IP by providing insights into market trends, competitive dynamics, and effective positioning, using the Innovation Spotlight service for enhanced exposure to thought leaders and the wider community.
Find Out More